News
Vir Biotechnology, Inc. (NASDAQ:VIR) is favoured by institutional owners who hold 53% of the company
Key Insights Given the large stake in the stock by institutions, Vir Biotechnology's stock price might be vulnerable ...
International Emmy-winning comedian-actor Vir Das is set to debut as an author with a memoir titled The Outsider: A Memoir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results